Infectious Disease Alert – May 1, 2012
May 1, 2012
View Issues
-
Abstract & Commentary: TB in the U.S. — Things Continue to Improve, But There is a Long Road Ahead
While the incidence decreased in all racial and ethnic groups, in Asians it decreased by only 0.6%. while in non-Hispanic whites it decreased by 6.2%. -
Abstract & Commentary: Nasopharyngeal Bacterial Changes with Antimicrobials and Pneumococcal Vaccine
A total of 153 nasopharyngeal swabs were collected as part of a nationwide study in Switzerland from children <2 years of age treated for acute otitis media from 2004-2009. -
Abstract & Commentary: Age of Primary Epstein-Barr Virus Infection Affects Immune Control
Infants in an area with high malaria exposure were infected with EBV at a significantly younger age in infancy, with a much higher incidence of primary EBV infection before 6 months of age. -
Pharmacology Update: Ivermectin Lotion 0.5% (Sklice)
A new topical preparation for the treatment of head lice has been approved by the FDA. Ivermectin is a macrocyclic lactone antibiotic that has been used orally both on and off label for head lice since 2001. -
Case Report & Commentary: Cystic Cerebellar Lesions Post Honeymoon: A Strange Case of Neurocysticercosis
Case Summary: A 27-year-old physical education teacher presented with two separate episodes of ill-defined dizziness and mild confusion over a period of one week. -
Abstract & Commentary: Dengue in Pediatric Travelers
A retrospective review of pediatric cases of dengue fever was undertaken at a single health center in the Bronx area of New York. Over a 3 ½ year period, eight children with dengue infection were identified. -
Updates By Carol A. Kemper, MD, FACP
In response to concerns that too much, and possibly unnecessary, surgery is undertaken in developing countries, especially in the elderly, these authors remind us that the vast majority of people around the globe requiring surgery don't get it. -
Pharmacology Watch: Does Aspirin Prevent Cancer?
In this issue: Aspirin and cancer prevention; rivaroxaban for pulmonary embolism; new rhinosinusitis practice guidelines; and FDA actions. -
Clinical Briefs in Primary Care supplement